Literature DB >> 28379475

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?

Benjamin Seeliger1,2, Jan Sznajd2,3, Joanna C Robson2, Andrew Judge2,4, Anthea Craven2, Peter C Grayson5, Ravi S Suppiah6, Richard A Watts7, Peter A Merkel8, Raashid A Luqmani2.   

Abstract

Objectives: Advances in diagnostic techniques have led to better distinction between types of vasculitis, potentially affecting the utility of the 1990 ACR classification criteria for vasculitis. This study tested the performance of these criteria in a contemporary vasculitis cohort.
Methods: The Diagnosis and Classification in Vasculitis Study provided detailed clinical, serological, pathological and radiological data from patients with primary systemic vasculitis and clinical context-specific comparator conditions. Fulfilment of six ACR criteria sets and their diagnostic performance was evaluated in patients with a given type of vasculitis and its comparator conditions.
Results: Data from 1095 patients with primary systemic vasculitis and 415 with comparator conditions were available. For classification, sensitivities and specificities for ACR classification criteria were, respectively, 81.1% and 94.9% for GCA; 73.6% and 98.3% for Takayasu's arteritis; 65.6% and 88.7% for granulomatosis with polyangiitis; 57.0% and 99.8% for eosinophilic granulomatosis with polyangiitis; 40.6% and 87.8% for polyarteritis nodosa; 28.9% and 88.5% for microscopic polyangiitis; and 72.7% and 96.3% for IgA-vasculitis. Overall sensitivity was 67.1%. Of cases identified by their respective criteria, 16.9% also met criteria for other vasculitides. Diagnostic specificity ranged from 64.2 to 98.9%; overall, 113/415 comparators (27.2%) fulfilled at least one of the ACR classification criteria sets.
Conclusion: Since publication of the ACR criteria for vasculitis, the sensitivity for each type of vasculitis, except GCA, has diminished, although the specificities have remained high, highlighting the need for updated classification criteria.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  Churg–Strauss syndrome; Takayasu’s disease; anti-neutrophil cytoplasm antibody; giant cell arteritis; microscopic polyangiitis; polyarteritis nodosa; vasculitis

Mesh:

Year:  2017        PMID: 28379475      PMCID: PMC6251621          DOI: 10.1093/rheumatology/kex075

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  15 in total

1.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods.

Authors:  D A Bloch; B A Michel; G G Hunder; D J McShane; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; J F Fries; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

2.  EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.

Authors:  Neil Basu; Richard Watts; Ingeborg Bajema; Bo Baslund; Thorsten Bley; Maarten Boers; Paul Brogan; Len Calabrese; Maria C Cid; Jan Willem Cohen-Tervaert; Luis Felipe Flores-Suarez; Shouichi Fujimoto; Kirsten de Groot; Loic Guillevin; Gulen Hatemi; Thomas Hauser; David Jayne; Charles Jennette; Cees G M Kallenberg; Shigeto Kobayashi; Mark A Little; Alfred Mahr; John McLaren; Peter A Merkel; Seza Ozen; Xavier Puechal; Niels Rasmussen; Alan Salama; Carlo Salvarani; Caroline Savage; David G I Scott; Mårten Segelmark; Ulrich Specks; Cord Sunderköetter; Kazuo Suzuki; Vladimir Tesar; Allan Wiik; Hasan Yazici; Raashid Luqmani
Journal:  Ann Rheum Dis       Date:  2010-05-06       Impact factor: 19.103

3.  ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).

Authors:  Anthea Craven; Joanna Robson; Cristina Ponte; Peter C Grayson; Ravi Suppiah; Andrew Judge; Richard Watts; Peter A Merkel; Raashid A Luqmani
Journal:  Clin Exp Nephrol       Date:  2013-08-31       Impact factor: 2.801

4.  Churg-Strauss syndrome in a district hospital.

Authors:  A J Reid; B D Harrison; R A Watts; S W Watkin; B G McCann; D G Scott
Journal:  QJM       Date:  1998-03

5.  Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group.

Authors:  L Guillevin; F Lhote; J Amouroux; R Gherardi; P Callard; P Casassus
Journal:  Br J Rheumatol       Date:  1996-10

Review 6.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

7.  Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis.

Authors:  J K Rao; N B Allen; T Pincus
Journal:  Ann Intern Med       Date:  1998-09-01       Impact factor: 25.391

8.  A comparison of two nomenclature systems for primary systemic vasculitis.

Authors:  I N Bruce; A L Bell
Journal:  Br J Rheumatol       Date:  1997-04

9.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

Authors:  Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more
  22 in total

1.  F-18 FDG PET for assessment of disease activity of large vessel vasculitis: A systematic review and meta-analysis.

Authors:  Sang-Woo Lee; Seong-Jang Kim; Youngduk Seo; Shin Young Jeong; Byeong-Cheol Ahn; Jaetae Lee
Journal:  J Nucl Cardiol       Date:  2018-08-17       Impact factor: 5.952

2.  Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.

Authors:  Berit Dalsgaard Nielsen; Lars Christian Gormsen; Ib Tønder Hansen; Kresten Krarup Keller; Philip Therkildsen; Ellen-Margrethe Hauge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-18       Impact factor: 9.236

Review 3.  Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis.

Authors:  Marco Folci; Giacomo Ramponi; Virginia Solitano; Enrico Brunetta
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-30       Impact factor: 10.817

Review 4.  Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.

Authors:  Daigo Nakazawa; Sakiko Masuda; Utano Tomaru; Akihiro Ishizu
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

5.  Validation of the provisional seven-item criteria for the diagnosis of polyarteritis nodosa.

Authors:  Gsrsnk Naidu; Chirag Rajkumar Kopp; Vikas Sharma; Manphool Singhal; Benzeeta Pinto; Varun Dhir; Ritambhra Nada; Ranjana W Minz; Sanjay Jain; Aman Sharma
Journal:  Rheumatol Int       Date:  2021-04-27       Impact factor: 2.631

6.  Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.

Authors:  L K Brekke; A P Diamantopoulos; B-T Fevang; J Aβmus; E Esperø; C G Gjesdal
Journal:  Arthritis Res Ther       Date:  2017-12-15       Impact factor: 5.156

Review 7.  TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?

Authors:  Bérenger Largeau; Anne-Claire Dupont; Denis Guilloteau; Maria-João Santiago-Ribeiro; Nicolas Arlicot
Journal:  Contrast Media Mol Imaging       Date:  2017-09-25       Impact factor: 3.161

8.  Optic Neuropathy Secondary to Polyarteritis Nodosa, Case Report, and Diagnostic Challenges.

Authors:  Kristian A Vazquez-Romo; Adrian Rodriguez-Hernandez; Jose A Paczka; Moises A Nuño-Suarez; Alberto D Rocha-Muñoz; Maria G Zavala-Cerna
Journal:  Front Neurol       Date:  2017-09-20       Impact factor: 4.003

9.  Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis.

Authors:  Elisabeth De Smit; Samuel W Lukowski; Lisa Anderson; Anne Senabouth; Kaisar Dauyey; Sharon Song; Bruce Wyse; Lawrie Wheeler; Christine Y Chen; Khoa Cao; Amy Wong Ten Yuen; Neil Shuey; Linda Clarke; Isabel Lopez Sanchez; Sandy S C Hung; Alice Pébay; David A Mackey; Matthew A Brown; Alex W Hewitt; Joseph E Powell
Journal:  BMC Med Genomics       Date:  2018-07-23       Impact factor: 3.063

10.  A case of anti-VEGF therapy application in Takayasu arteries with retinopathy.

Authors:  Qiaoyun Gong; Tianwei Qian; Feng'e Chen; Xun Xu; Weijun Wang
Journal:  Am J Ophthalmol Case Rep       Date:  2020-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.